Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine

Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine

US Patent 8716013 · Granted May 6, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use f2024
Lassa vaccine2024
Recombinant measles virus expressing zika virus prM and E proteins2024
Lentiviral vector-based Japanese encephalitis immunogenic composition2023
Lentiviral vector-based Japanese encephalitis immunogenic composition2023
Lentiviral vector-based Japanese encephalitis immunogenic composition2023
Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a2022
Recombinant measles vaccine expressing hTERT2022
Live recombinant measles-M2 virus—its use in eliciting immunity against influenz2021
Dengue virus chimeric polyepitope composed of fragments of non-structural protei2021
Compositions and methods comprising measles virus defective interfering particle2021
Use of a genetically modified infectious measles virus with enhanced pro-apoptot2021